BioCentury
ARTICLE | Company News

Acambis in vaccine deal

March 16, 2001 8:00 AM UTC

Acambis (LSE:ACM; ACAM) closed a deal with Swiss Serum & Vaccine Institute Berne (Berne, Switzerland) to jointly develop a single dose oral combination vaccine to protect against typhoid and cholera. ...